Muir Kevin
Known title: GM INTERVENTIONAL ONCOLOGYCIK: 0001929335
Associated companies
Transaction History
| DCTH | ▲ Buy | Grant | 13,441 | $50K | 3/19/2024 | View on chart |
| DCTH | ▲ Buy | Grant | 13,441 | $50K | 3/19/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Veracyte stock moves; DCTH shows no related news
Recent news coverage focuses on Veracyte (VCYT) rather than Delcath Systems (DCTH). There are no specific reports or announcements regarding DCTH in the provided data. The stock currently trades with a high trailing P/E ratio, while analyst targets remain above the current price level.
Veracyte stock moves; DCTH shows no related news. Recent news coverage focuses on Veracyte (VCYT) rather than Delcath Systems (DCTH). There are no specific reports or announcements regarding DCTH in the provided data. The stock currently trades with a high trailing P/E ratio, while analyst targets remain above the current price level.